Home >> Proteases >> Proteasome >>

Proteasome Inhibitors

Cat.No. Product Name Information Publication Customer Review
S2619 MG-132 MG-132 (ZLLLal) is potent inhibitor of proteasome with IC50 of 100 nM. (7)
S2853 Carfilzomib (PR-171) Carfilzomib (PR-171) is a proteasome inhibitor with IC50 less than 5 nM.
S2181 MLN9708 MLN9708 is a selective inhibitor of chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM. (2)
S2180 MLN2238 MLN2238 inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM, respectively. (1)
S1183 Danoprevir Danoprevir is a peptidomimetic inhibitor of the NS3/4A protease of hepatitis C virus (HCV) with IC50 of 0.2-3.5 nM. (3)
S1157 Delanzomib (CEP-18770) CEP-18770 is a potent chymotrypsin-like proteasome inhibitor with IC50 of 3.8 nM.
S7049 Oprozomib (ONX 0912) Oprozomib (ONX 0912) selectively inhibits CT-L activity of 20S proteasome β5/LMP7 with IC50 of 36 nM/82 nM.
S7038 Epoxomicin (BU-4061T)
S7021 GS-9256 GS-9256 is a novel phosphinic acid derived inhibitor of the HCV NS3/4A protease with IC50 of 4 nM.